Program Description: 

This conference focuses on outcomes research in chronic kidney disease and end-stage kidney disease, delivery of care in dialysis units and chronic kidney disease clinics, emerging data on new treatments compared to current standard fo care, review of kidney pathology, and basic science research that may become future therapeutics.

Key Words: Nephrology, Clinical Trials, Research

Target audience: 
  • Physicians
  • Nurse Practitioners
  • Physician Assistants
  • Trainees, Medical Students
Learning objectives: 

Participants who engage in this educational intervention will be able to:

  • Identify the pathophysiological rationale for using vasoconstrictors like terlipressin or norepinephrine in hepatorenal syndrome, including their effects on splanchnic vasodilation and renal perfusion.
  • Compare the efficacy, dosing regimens, and administration routes of terlipressin versus norepinephrine in the management of hepatorenal syndrome, based on clinical trial data and guidelines.
  • Identify key monitoring parameters, potential adverse effects, and practical pearls for optimizing outcomes and minimizing complications when treating hepatorenal syndrome with terlipressin or norepinephrine.
Faculty & credentials: 
Activity Director(s):
Christina Mariyam Joy, MD
Associate Professor
Department of Medicine
Division of Nephrology
Medical College of Wisconsin
 
Speaker:
Kevin R Regner, MD, MS, FASN
Professor
Interim Chair
Department of Medicine
Medical College of Wisconsin
 
 
In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all persons in control of content must disclose any relevant financial relationships. It is the policy of the Medical College of Wisconsin to identify, mitigate and disclose the absence or presence of all relevant financial relationships with ineligible companies held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education. The following in control of content had no relevant financial relationships to disclose.
  • Christina Mariyam Joy
 

he following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.

Name

Company

Role

Kevin R Regner

Mallinkcrodt Pharma

Advisory Committee

 

Contact

Name: 
Cori Wilinski
Email: 
[email protected]

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.00 hours of participation for continuing education for allied health professionals.

Session date: 
11/11/2025 - 3:30pm to 4:30pm CST
Location: 
HUB for Collaborative Medicine 7th Floor, Room 7150
Wauwatosa, WI 53226
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.
Please login or register to take this course.